This HTML5 document contains 183 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n16	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n18	http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000778/
n3	http://linked.opendata.cz/ontology/sukl/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029631/price-of-originator/
n15	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n12	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029631/reimbursement/
skos	http://www.w3.org/2004/02/skos/core#
n5	http://linked.opendata.cz/resource/sukl/indgroup/
n19	http://linked.opendata.cz/resource/sukl/packing/
n13	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029631/
n10	http://linked.opendata.cz/resource/sukl/company/
n6	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029631/core-reimbursement/
n11	http://linked.opendata.cz/resource/sukl/active-ingredient/
n14	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029631/price/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n20	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n17	http://linked.opendata.cz/resource/atc/
n8	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0029631

rdf:type

n3:MedicinalProductPackaging

dcterms:title

ABRAXANE 5 MG/ML

skos:notation

0029631

n3:hasATCCode

n17:L01CD01

n3:hasActiveIngredient

n11:PACLITAXELUM

n3:hasDefinedDailyDose

n13:ddd

n3:hasDosageForm

n8:INF-PLV-SUS-IVN

n3:hasPackagingSize

1

n3:hasPacking

n19:VIA

n3:hasRegistrationHolder

n10:CEWGB

n3:hasRegistrationState

n20:R

n3:hasRouteOfAdministration

n16:IVN

n3:hasStrength

100MG

n3:hasIndicationGroup

n5:44

n3:hasSpecializationRestriction

n15:ONK

n3:containsDefinedDailyDoses

0.0

n3:hasRegistrationCode

EU/1/07/428/001

n3:hasTitleSupplement

IVN INF PLV SUS 1X100MG

n3:containsUsualTherapeuticalDailyDoses

4.6688

n3:hasCoreReimbursementSpecification

n6:2013-08-01 n6:2013-08-03 n6:2013-06-01 n6:2013-07-01 n6:2013-04-01 n6:2013-05-01 n6:2013-02-01 n6:2013-03-01 n6:2014-03-01 n6:2014-04-01 n6:2014-01-01 n6:2014-02-01 n6:2013-11-01 n6:2013-12-01 n6:2013-09-01 n6:2013-10-01 n6:2013-01-01 n6:2013-01-05 n6:2015-07-01 n6:2015-07-02 n6:2015-05-01 n6:2015-06-01 n6:2015-04-01 n6:2015-04-02 n6:2014-09-01 n6:2014-10-01 n6:2014-07-03 n6:2014-08-01 n6:2014-06-13 n6:2014-07-01 n6:2014-05-01 n6:2014-06-01 n6:2015-02-01 n6:2015-03-01 n6:2015-01-01 n6:2015-01-13 n6:2014-11-19 n6:2014-12-01 n6:2014-10-02 n6:2014-11-01

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-01-01 n4:2013-01-05 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-07-01 n4:2015-07-02 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13

n3:hasPriceSpecification

n14:2015-07-01 n14:2015-07-02 n14:2015-04-01 n14:2015-04-02 n14:2015-05-01 n14:2015-06-01 n14:2014-01-01 n14:2014-02-01 n14:2014-03-01 n14:2014-04-01 n14:2013-09-01 n14:2013-10-01 n14:2013-11-01 n14:2013-12-01 n14:2013-06-01 n14:2013-07-01 n14:2013-08-01 n14:2013-08-03 n14:2013-02-01 n14:2013-03-01 n14:2013-04-01 n14:2013-05-01 n14:2015-01-01 n14:2015-01-13 n14:2015-02-01 n14:2015-03-01 n14:2014-10-02 n14:2014-11-01 n14:2014-11-19 n14:2014-12-01 n14:2014-07-03 n14:2014-08-01 n14:2014-09-01 n14:2014-10-01 n14:2014-05-01 n14:2014-06-01 n14:2014-06-13 n14:2014-07-01 n14:2013-01-01 n14:2013-01-05

n3:hasReimbursementSpecification

n12:2015-07-01 n12:2015-07-02 n12:2015-05-01 n12:2015-06-01 n12:2015-04-01 n12:2015-04-02 n12:2015-02-01 n12:2015-03-01 n12:2015-01-01 n12:2015-01-13 n12:2014-11-19 n12:2014-12-01 n12:2014-10-02 n12:2014-11-01 n12:2013-08-01 n12:2013-08-03 n12:2013-06-01 n12:2013-07-01 n12:2013-04-01 n12:2013-05-01 n12:2013-02-01 n12:2013-03-01 n12:2013-01-01 n12:2013-01-05 n12:2014-09-01 n12:2014-10-01 n12:2014-07-03 n12:2014-08-01 n12:2014-06-13 n12:2014-07-01 n12:2014-05-01 n12:2014-06-01 n12:2014-03-01 n12:2014-04-01 n12:2014-01-01 n12:2014-02-01 n12:2013-11-01 n12:2013-12-01 n12:2013-09-01 n12:2013-10-01

n3:hasUsualTherapeuticalDailyDose

n13:utdd

n3:spcFile

http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000778%2FWC500020435.pdf

n3:spcUri

n18:WC500020435.pdf